AzurRx engages CROs Rho and Linical in separate Phase II trials in cystic fibrosis with pancreatic insufficiency
AzurRx BioPharma is working with CROs Rho and Linical for its Phase II and Phase IIb MS1819 trials, respectively, in cystic…
AzurRx BioPharma is working with CROs Rho and Linical for its Phase II and Phase IIb MS1819 trials, respectively, in cystic…
Novavax’s South Africa-based Phase IIb trial investigating its COVID-19 vaccine NVX-CoV2373 has results likely to be revealed within the next…
Biotechnology firm Codagenix and Serum Institute of India (SII) have dosed the first patient in Phase I clinical trial of a single-dose, intranasal Covid-19 vaccine,…
Imperial College London in the UK has reported that the REMAP-CAP trial of two arthritis drugs, tocilizumab and sarilumab may reduce mortality in sickest Covid-19…
German company CureVac has enrolled the first participant in the pivotal Phase IIb/III HERALD study to evaluate the safety and…
AstraZeneca has reported that interim analysis from the Phase III programme of the Covid-19 vaccine, AZD1222, showed it is safe…
Indian firm Bharat Biotech will be commencing Phase I trials of its intranasal Covid-19 vaccine candidate next month. PTI reported…
UK Biobank has announced that a consortium of ten biopharma companies will conduct a study to analyse circulating concentrations of…
New Zealand’s handling of its Covid-19 outbreak is the envy of the world. To date, the country of 5 million…
German company CureVac has enrolled the first participant in the pivotal Phase IIb/III HERALD study to evaluate the safety and…
Pre-filled syringes are regarded as one of the most effective medical devices of administering medications to patients. The rapidly increasing…
Cytiva opened a new facility for manufacturing Xcellerex XDR bioreactors in Shrewsbury, Massachusetts, US, in December 2020. The new manufacturing…
Last year, there was significant focus on the pharmaceutical industry as the race for Covid-19 treatments and vaccine began. With…
OpenClinica is pleased to announce that it will be featured on public television series In Depth, showcasing its clinical trials…